Pauls Matthew
- SEC CIK
- 0001573429
In the past year, 2 open-market sale filings worth $37.0K and no purchases.
Current role at each company
- PTHS Pelthos Therapeutics Inc.Directoras of Jul 7, 2026
- PVLA Palvella Therapeutics, Inc.Directoras of Jul 1, 2026
- SLNO Soleno Therapeutics IncDirectoras of May 18, 2026
- SVRA Savara IncCHIEF EXECUTIVE OFFICERas of Dec 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $37.0K
- 2 filings
- Net
- −$37.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pauls Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTHS Pelthos Therapeutics Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Pauls MatthewDirector | SSale | −786 | $20.92 | −$16.4K | −4.9%15.2K after | 2 lots10b5-1 |
| Jul 7, 2026 (view filing)5:03 PM ET | Jul 2 | 5 days | Pauls MatthewDirector | SSale | −786 | $26.16 | −$20.6K | −5.2%14.4K after | 2 lots10b5-1 |
SLNO Soleno Therapeutics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 (view filing) | Mar 28 | 3 days | Pauls MatthewDirector | SSale | −5.94K | $71.55 | −$424.8K | −47.7%6.50K after |
SVRA Savara Inc
CHIEF EXECUTIVE OFFICER6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 17-18 | 1 day | Pauls MatthewCHIEF EXECUTIVE OFFICER | PPurchase | +26.9K | $1.18 | +$31.9K | +8.5%345.0K after | 2 lots |
| Nov 22, 2021 (view filing) | Nov 18-19 | 4 days | Pauls MatthewCHIEF EXECUTIVE OFFICER | PPurchase | +22.1K | $1.10 | +$24.4K | +6.4%367.2K after | 3 lots |
| Dec 2, 2021 (view filing) | Dec 2 | Same day | Pauls MatthewCHIEF EXECUTIVE OFFICER | PPurchase | +10.0K | $1.10 | +$11.0K | +2.7%377.2K after | |
| Dec 8, 2021 (view filing) | Dec 8 | Same day | Pauls MatthewCHIEF EXECUTIVE OFFICER | PPurchase | +6.50K | $1.06 | +$6.89K | +1.7%383.7K after | |
| Dec 29, 2023 (view filing) | Dec 28 | 1 day | Pauls MatthewCHIEF EXECUTIVE OFFICER | SSale | −84.0K | $4.71 | −$395.6K | −6.1%1.30M after | |
| Dec 16, 2024 (view filing) | Dec 16 | Same day | Pauls MatthewCHIEF EXECUTIVE OFFICER | SSale | −54.7K | $3.31 | −$181.1K | −3.4%1.54M after |